Structural design of the anti-TNFα therapeutic NANOBODY® compound, ozoralizumab, to support its potent and sustained clinical efficacy
-
Published:2024-11
Issue:
Volume:734
Page:150454
-
ISSN:0006-291X
-
Container-title:Biochemical and Biophysical Research Communications
-
language:en
-
Short-container-title:Biochemical and Biophysical Research Communications
Author:
Mima MasashiORCID,
Mishima-Tsumagari Chiemi,
Nakano Koichiro,
Morimoto Mai,
Ogata Hitoshi,
Sakata Mayumi,
Iwaoka Ryo,
Iwata Katsuya,
Hachiuma Kenji,
Iwamoto Kunihiko,
Fujii Yasuyuki,
Kurokawa Tomofumi